JP2024507550A5 - - Google Patents
Info
- Publication number
- JP2024507550A5 JP2024507550A5 JP2023550695A JP2023550695A JP2024507550A5 JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5 JP 2023550695 A JP2023550695 A JP 2023550695A JP 2023550695 A JP2023550695 A JP 2023550695A JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- compound according
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163152356P | 2021-02-23 | 2021-02-23 | |
| US63/152,356 | 2021-02-23 | ||
| PCT/US2022/017134 WO2022182604A1 (en) | 2021-02-23 | 2022-02-21 | Compounds useful in hiv treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507550A JP2024507550A (ja) | 2024-02-20 |
| JP2024507550A5 true JP2024507550A5 (cg-RX-API-DMAC7.html) | 2025-03-05 |
Family
ID=80685329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550695A Withdrawn JP2024507550A (ja) | 2021-02-23 | 2022-02-21 | Hiv療法に有用な化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240182510A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4298105A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024507550A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022182604A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4358968A4 (en) * | 2021-06-22 | 2025-05-07 | Rome Therapeutics, Inc. | 4-ETHINYL-3-HYDROXY-TETRAHYDROFURANYL ADENINE PHOSPHORAMIDATE AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| WO2002074769A1 (en) | 2001-03-19 | 2002-09-26 | Ono Pharmaceutical Co., Ltd. | Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient |
| CA2502109C (en) * | 2004-03-24 | 2010-02-23 | Yamasa Corporation | 4'-c-substituted-2-haloadenosine derivative |
| WO2013187978A1 (en) * | 2012-06-16 | 2013-12-19 | Nanjing Molecular Research, Inc. | Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs |
| PH12021500034A1 (en) * | 2019-03-06 | 2022-06-06 | Glaxosmithkline Ip No 2 Ltd | Compounds useful in hiv therapy |
| KR102987126B1 (ko) * | 2020-03-20 | 2026-07-07 | 길리애드 사이언시즈, 인코포레이티드 | 4'-c-치환된-2-할로-2'-데옥시아데노신 뉴클레오시드의 프로드러그 및 이의 제조 및 사용 방법 |
-
2022
- 2022-02-21 WO PCT/US2022/017134 patent/WO2022182604A1/en not_active Ceased
- 2022-02-21 EP EP22709474.5A patent/EP4298105A1/en active Pending
- 2022-02-21 JP JP2023550695A patent/JP2024507550A/ja not_active Withdrawn
- 2022-02-21 US US18/547,001 patent/US20240182510A1/en active Pending